Potassium channels: possible new therapeutic targets in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Medical Hypotheses

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mehy.2008.05.021PMID 18650029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.

  2008cited by this paper
• Advances in the treatment of Parkinson's disease.

  2007influential reference
• Potassium channel blockers and openers as CNS neurologic therapeutic agents.

  2007cited by this paper
• ATP-sensitive potassium channels: novel potential roles in Parkinson’s disease

  2007cited by this paper
• ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease

  2007cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Modulation of potassium channels as a therapeutic approach.

  2006influential reference
• A channel to neurodegeneration

  2006influential reference
• A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity.

  2006cited by this paper
• Pore‐forming subunits of K‐ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain

  2005cited by this paper
• K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons

  2005cited by this paper
• Comparative immunohistochemical distribution of three small-conductance Ca2+-activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain.

  2004cited by this paper
• Kv3.4 subunits enhance the repolarizing efficiency of Kv3.1 channels in fast-spiking neurons

  2003cited by this paper
• Kir2 potassium channels in rat striatum are strategically localized to control basal ganglia function.

  2003cited by this paper
• Mediation of Neuronal Apoptosis by Kv2.1-Encoded Potassium Channels

  2003cited by this paper
• Alzheimer's disease and Parkinson's disease.

  2003cited by this paper
• Therapeutic potential of potassium channel modulators for CNS disorders

  2003cited by this paper
• Selective Coupling of T-Type Calcium Channels to SK Potassium Channels Prevents Intrinsic Bursting in Dopaminergic Midbrain Neurons

  2002cited by this paper
• Molecular physiology of neuronal K-ATP channels

  2001cited by this paper
• Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS.

  2001cited by this paper
• The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.

  2000cited by this paper
• The Neuroprotective Agent Riluzole Activates the Two P Domain K+ Channels TREK-1 and TRAAK

  2000cited by this paper
• Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Immunohistochemical study on the distribution of six members of the Kv1 channel subunits in the rat basal ganglia.

  2000cited by this paper
• Potassium channels: basic aspects, functional roles, and medical significance.

  1999cited by this paper

• Magnesium Ions as Modulators of Voltage-Gated and Ligand-Gated Ion Channels in Central Neurons

  2025cites this paper
• ATP-sensitive potassium channels: a double-edged sword in neurodegenerative diseases.

  2022cites this paper
• Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels

  2021cites this paper
• Mitochondrial K+ channels and their implications for disease mechanisms.

  2021cites this paper
• Potassium channels and their emerging role in Parkinson's disease.

  2020cites this paper
• Medicinal Chemistry of Potassium Channel Modulators: An update of Recent Progress (2011-2017).

  2019cites this paper
• Mechanisms by which fibroblast growth factor 20 improves motor performance in a mouse model of Parkinson’s disease

  2019cites this paper
• Physiological Roles and Therapeutic Potential of Ca2+ Activated Potassium Channels in the Nervous System

  2018cites this paper
• Mitochondrial potassium channels in cell death.

  2017cites this paper
• Diversity of astroglial responses across human neurodegenerative disorders and brain aging

  2017cites this paper
• Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences

  2017cites this paper
• Potassium Channels: A Potential Therapeutic Target for Parkinson’s Disease

  2017cites this paper
• Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model

  2017cites this paper
• The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells

  2017cites this paper
• Acute action of rotenone on excitability of catecholaminergic neurons in rostral ventrolateral medulla.

  2017cites this paper
• Sodium and Potassium Relating to Parkinson's Disease and Traumatic Brain Injury.

  2016cites this paper
• 4-aminopyridine decreases MPTP-induced behavioral disturbances in animal model of Parkinson’s disease

  2016cites this paper
• Astrocytes as new targets to improve cognitive functions.

  2016cites this paper
• Effect of potassium channel blocker Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson's disease in rats

  2016cites this paper
• EFFECT OF POTASSIUM CHANNEL BLOCKER 4-AMINOPYRIDINE PRETREATMENT ON THE 6-OHDA-INDUCED PARKINSON'S DISEASE IN RATS

  2015cites this paper
• K(ATP) channel block prevents proteasome inhibitor-induced apoptosis in differentiated PC12 cells.

  2015cites this paper
• Voltage-Gated potassium channel KV1.5 protects against MPP

  2015cites this paper
• Voltage-Gated potassium channel KV1.5 protects against MPP + mediated neurotoxicity in PC12 cells

  2014cites this paper
• SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.

  2014cites this paper
• Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons

  2014cites this paper
• Potassium channels: a review of broadening therapeutic possibilities for neurological diseases

  2013cites this paper
• Mitochondrial Small Conductance SK2 Channels Prevent Glutamate-induced Oxytosis and Mitochondrial Dysfunction*

  2013cites this paper
• Chronic dopamine depletion augments the functional expression of K-ATP channels in the rat subthalamic nucleus.

  2012cites this paper
• The subtype specific roles of SK2 and SK3 channels in dopamine neurons of the substantia nigra

  2012cites this paper
• Ether-à-go-go 1 (Eag1) Potassium Channel Expression in Dopaminergic Neurons of Basal Ganglia is Modulated by 6-Hydroxydopamine Lesion

  2011cites this paper
• Progesterone blocks multiple routes of ion flux.

  2011cites this paper
• Verification of expressions of Kir2 as potential peripheral biomarkers in lymphocytes from patients with Parkinson's disease.

  2011cites this paper
• Construction and Functional Analysis of Human Genetic Interaction Networks with Genome-wide Association Data

  2011cites this paper
• Modulation of the activity of dopaminergic neurons by SK channels: a potential target for the treatment of Parkinson’s disease?

  2010cites this paper
• Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease

  2010cites this paper
• Modulation of the activity of dopaminergic neurons by SK channels: a potential target for the treatment of Parkinson’s disease?

  2010cites this paper
• Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons

  year unknowncites this paper